Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

NET 3Endocrine 3Sarcoma 1Gastrointestinal 1

Conditions

Breast Neoplasms 133Neoplasms 114Prostatic Neoplasms 63Lung Neoplasms 47Head and Neck Neoplasms 46Colorectal Neoplasms 35Ovarian Neoplasms 33Uterine Cervical Neoplasms 28Endometrial Neoplasms 23Motor Activity 22Neoplasm Metastasis 20Multiple Myeloma 19Brain Neoplasms 19Pancreatic Neoplasms 18Rectal Neoplasms 17Lymphoma 16Fatigue 16Carcinoma, Non-Small-Cell Lung 16Pain 15Gastrointestinal Neoplasms 15Colonic Neoplasms 15Leukemia 14Depression 14Oropharyngeal Neoplasms 13Urinary Bladder Neoplasms 12Melanoma 12Hematologic Neoplasms 12Esophageal Neoplasms 12Anxiety Disorders 12Stomach Neoplasms 11

Interventions

lutetium Lu 177 dotatate 29Everolimus 19Temozolomide 11gallium Ga 68 dotatate 10Nivolumab 10Magnetic Resonance Spectroscopy 10Capecitabine 9pembrolizumab 8lanreotide 8Positron Emission Tomography Computed Tomography 8cabozantinib 73-Iodobenzylguanidine 7177Lu-octreotide, DOTA(0)-Tyr(3)- 7Somatostatin 690Y-octreotide, DOTA-Tyr(3)- 6telotristat ethyl 5lenvatinib 5Octreotide 5Lutetium-177 5Ga(III)-DOTATOC 5Fluorodeoxyglucose F18 5Carboplatin 5avelumab 4Positron-Emission Tomography 4Ipilimumab 4Bevacizumab 4surufatinib 3pasireotide 3fluorodopa F 18 3copper dotatate CU-64 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Neuroendocrine Tumors × Surveys and Questionnaires × Clear all
NCT07258810 2025-12-02

ETP-NET

Hospices Civils de Lyon

Not yet recruiting
100 enrolled
EndocrineNET

Neoplasms, Neuroendocrine Tumors

NCT03289741 2025-05-09

A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide

Memorial Sloan Kettering Cancer Center

Phase 4 Completed
51 enrolled 10 charts
EndocrineNET

Neuroendocrine Tumors

NCT04077372 2023-01-27

Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers

Stanford University

Phase NA Terminated
12 enrolled
EndocrineGastrointestinalNETSarcoma

Esophageal Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma, Neuroendocrine Tumors, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡